Replies to post #63633 on Amarin Corp Plc (AMRN)

[rosemountbomber]

They sound reasonably confident is R-I success - at full readout and not at interim.

We would just have to hang in there for 2 1/2 more years, meaning hopefully is able to increase scripts and possibly get some cash with some partnership deals. Unfortunately hard to imagine those being very lucrative with R-I results.

Maybe because of the long time horizon this does not seem to be boosting the stock much this morning.

[sts66]

We argue that as part of the sales promotion/physician education process, this advantageous lipid profile would not escape physicians’ attention

But apparently Lovaza causing up to a 49% rise in LDL-C *has* escaped the good doctor's attentions for > 15 yrs......hard to believe they'd simply ignore it given LDL-C's sole accepted lipid marker for elevated CV risk.....